OGT delivers superior MRD detection capabilities with new SureSeq Myeloid MRD Panel
OGT
Ultralow variant detection enables a stronger characterization of a sample’s current AML status
Leukemia
New Guidelines for Managing Blood Cancers in Pregnancy
Macquarie University
About 12.5 pregnancies per 100,000 are affected by blood cancers, and their incidence has been rising
Testing for Residual Cancer before Blood Cell Transplant Is Crucial, Study Finds
Virginia Tech
New research highlights the feasibility of testing for lingering cancer cells for patients in remission from acute myeloid leukemia
New Computational Tool Characterizes Progenitor Cells in AML Patients
Center for Genomic Regulation
Findings may help reduce rates of relapse and improve the prognosis and successful treatment of acute myeloid lymphoma
Blood Test Identifies AML Patients at Risk of Posttransplant Relapse
National Institutes of Health
A small portion of acute myeloid leukemia patients in remission showed persisting mutations, which predicted their risk of death from cancer relapse
Pharmacotyping Provides a Blueprint for “True Precision Medicine”
St. Jude Children’s Research Hospital
Researchers have now comprehensively studied the pharmacogenomics of ALL revealing a wide variability
Key Molecule Driving the Progression of Chronic Leukemia Identified
Swathi Kodaikal, MSc
Further research can alter the prognosis and improve quality of life in patients with leukemia
International Reproducibility Efforts in Clinical Flow Cytometry
Zahraa Chorghay, PhD
How can we achieve interlaboratory standardization of flow cytometry assays?
Research Reveals High-Risk Subtype of Relapsed Pediatric AML
St. Jude Children’s Research Hospital
Scientists have found a previously overlooked mutation in a subtype of pediatric leukemia
Artificial Intelligence Helps Diagnose Leukemia
University of Bonn
Researchers at the University of Bonn show how machine learning improves the evaluation of blood analysis data